DE69226950T2 - Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt - Google Patents

Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt

Info

Publication number
DE69226950T2
DE69226950T2 DE69226950T DE69226950T DE69226950T2 DE 69226950 T2 DE69226950 T2 DE 69226950T2 DE 69226950 T DE69226950 T DE 69226950T DE 69226950 T DE69226950 T DE 69226950T DE 69226950 T2 DE69226950 T2 DE 69226950T2
Authority
DE
Germany
Prior art keywords
adhesion
long
gastrointestinal tract
term capsule
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69226950T
Other languages
English (en)
Other versions
DE69226950D1 (de
Inventor
Kouichi Nakamichi
Shogo Izumi
Hiroshi Fukui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of DE69226950D1 publication Critical patent/DE69226950D1/de
Publication of DE69226950T2 publication Critical patent/DE69226950T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69226950T 1991-04-08 1992-04-06 Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt Expired - Fee Related DE69226950T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10384691 1991-04-08
PCT/JP1992/000423 WO1992017166A1 (en) 1991-04-08 1992-04-06 Capsule

Publications (2)

Publication Number Publication Date
DE69226950D1 DE69226950D1 (de) 1998-10-15
DE69226950T2 true DE69226950T2 (de) 1999-05-12

Family

ID=14364803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226950T Expired - Fee Related DE69226950T2 (de) 1991-04-08 1992-04-06 Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt

Country Status (8)

Country Link
US (1) US5498422A (de)
EP (1) EP0580861B1 (de)
JP (1) JP2626248B2 (de)
AT (1) ATE170745T1 (de)
AU (1) AU1560692A (de)
CA (1) CA2107678A1 (de)
DE (1) DE69226950T2 (de)
WO (1) WO1992017166A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094756C (zh) * 1993-12-10 2002-11-27 藤泽药品工业株式会社 解热镇痛组合药剂
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US20020119192A1 (en) * 2000-09-22 2002-08-29 Vishwanathan Narayanan Badri Controlled release formulations for oral administration
EP1430887A1 (de) * 2000-10-12 2004-06-23 Boehringer Ingelheim Pharma GmbH & Co.KG Tiotropium-haltige Inhalationspulver
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030203055A1 (en) * 2002-03-15 2003-10-30 Cypress Bioscience, Inc. Methods of treating visceral pain syndromes
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
MXPA05000477A (es) * 2002-07-10 2005-03-23 Warner Lambert Co Composiciones gastrointestinales.
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
JP5406529B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
GEP20135986B (en) 2009-03-09 2013-12-10 Shashikant Prabhudas Kurani Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants
US20140228715A1 (en) * 2011-05-13 2014-08-14 The General Hospital Corporation Method and Apparatus for Delivering a Substance
EP2946774B1 (de) * 2014-05-19 2020-04-22 Tillotts Pharma AG Beschichtete Kapseln mit modifizierter Freisetzung
CA2956426C (en) 2014-08-11 2021-07-20 Perora Gmbh Method of inducing satiety
ES2774978T3 (es) 2014-08-11 2020-07-23 Perora Gmbh Formulación que comprende partículas
EP3319592A1 (de) 2015-07-07 2018-05-16 perora GmbH Verfahren zum hervorrufen von sättigung
CA2989511A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Edible composition comprising a polysaccharide and a lipid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002731A (en) * 1974-06-17 1977-01-11 Sterling Drug Inc. Diagnostic process using sodium tyropanoate
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
JPS587605B2 (ja) * 1977-09-08 1983-02-10 帝人株式会社 徐放性製剤およびその製造法
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
DE3400106A1 (de) * 1984-01-04 1985-07-11 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system

Also Published As

Publication number Publication date
EP0580861A1 (de) 1994-02-02
CA2107678A1 (en) 1992-10-09
WO1992017166A1 (en) 1992-10-15
JP2626248B2 (ja) 1997-07-02
ATE170745T1 (de) 1998-09-15
US5498422A (en) 1996-03-12
EP0580861B1 (de) 1998-09-09
DE69226950D1 (de) 1998-10-15
EP0580861A4 (de) 1994-03-21
AU1560692A (en) 1992-11-02

Similar Documents

Publication Publication Date Title
DE69226950T2 (de) Kapsel mit Langzeitwirkung fuer die Adhäsion im Gastrointestinaltrakt
AU7992987A (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch
ATE124255T1 (de) Im dickdarm zerfallende, polypeptide enthaltende orale formulierungen.
FR2625217B1 (fr) Composition d'adhesif active sous l'effet de la pression a base de copolymere acrylique
IT1212714B (it) Cattiva motilita'procedimento e formulazioni gastrointestinale. farmaceutiche per controllare la
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
AU4983893A (en) Sustained-release hydrogel preparation
ATE127019T1 (de) Antazida-zubereitung mit verlängerter magenverweilzeit.
IT9067586A0 (it) Miscela polimerica amidacea particolarmente per la produzione di film e simili e procedimento per la sua produzione.
CA2235401A1 (en) Method for sterilizing medical devices utilizing a room temperature sterilant
CA2016505A1 (en) Water soluble high molecular polymerized drug preparation
PT839525E (pt) Preparacao de libertacao prolongada
EP0179023A3 (en) With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
IT1229205B (it) Composizioni farmaceutiche agenti in particolare sul cuore e sul cuore e sul sistema cardiovascolare e procedimento per la loro preparazione.
GB2375340B (en) Gelatin substitute
IT1254898B (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
IT9047759A0 (it) Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT8222049A0 (it) Dispositivo di deposito per cedere sostanze biologicamente attive al tratto digerente.
DE69617868D1 (de) Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol
FR2718016B1 (fr) Dispositif externe permettant l'occlusion de l'urètre chez les incontinents de sexe masculin.
ES2164566A1 (es) Preparacion cosmetica o dermofarmaceutica compuesta de milicapsulas conrecubrimiento de polisacaridos cationicos.
CA2199612A1 (en) Implantable moulded body for administering active substances to plants
EP0850629A3 (de) Absorbierendes Element
Lee The Bruce Lee film image and its social implications

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee